CT-2103 in Combination With Gemcitabine in Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer|Breast Cancer
Interventions: DRUG: CT-2103|DRUG: Gemcitabine
Sponsor: M.D. Anderson Cancer Center
Collaborators: CTI BioPharma